LeMaitre Vascular, Inc. LMAT

81.52 0.70 0.87% as of 25 Sep
Market cap
$1.9B
P/E
28.1×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
249.60 219.86 193.48 161.65 154.42 129.37 117.23 105.57 100.87 89.15
Revenue Growth
13.53% 13.63% 19.69% 4.68% 19.37% 10.35% 11.05% 4.66% 13.14% 13.78%
Cost of Revenue
71.06 68.96 66.44 56.76 53.04 44.75 37.38 31.63 30.17 26.22
Gross Profit
178.54 150.90 127.05 104.90 101.38 84.62 79.85 73.94 70.70 62.94
R&D Expenses
14.14 15.65 16.97 13.29 11.80 10.10 9.28 8.20 6.64 6.14
SG&A Expenses
96.49 83.00 72.89 61.67 53.16 46.20 49.39 45.01 42.96 40.46
Operating Income
67.91 52.26 36.71 26.83 36.43 28.79 21.18 28.21 21.10 16.34
Non-operating Income/Expense
7.27 4.62 2.76 0.66 (2.14) (1.43) 0.50 0.24 0.00 (0.09)
Non-operating Interest Expenses
5.18 0.21 0.00 0.00 2.22 1.31 0.00 0.00 0.02 0.01
EBT
75.18 56.88 39.48 27.49 34.29 27.36 21.68 28.44 21.11 16.24
Income Tax Provision
17.45 12.84 9.37 6.85 7.38 6.14 3.75 5.50 3.93 5.65
Income after Tax
57.73 44.04 30.11 20.64 26.91 21.22 17.93 22.94 17.18 10.59
Dividends (Preferred)
0.00 0.00 — — 0.00 0.00 0.00 — 0.00 —
Net Income Common
57.73 44.04 30.11 20.64 26.91 21.22 17.93 22.94 17.18 10.59
EPS (Basic)
2.55 1.96 1.36 0.94 1.27 1.05 0.91 1.18 0.91 0.57
EPS (Diluted)
2.52 1.93 1.34 0.93 1.25 1.04 0.88 1.13 0.86 0.55
Shares (Basic, Weighted)
22.64 22.45 22.22 21.98 21.16 20.25 19.81 19.43 18.96 18.49
Shares (Diluted, Weighted)
22.93 22.78 22.42 22.17 21.48 20.48 20.33 20.24 20.03 19.24
Gross Margin
71.53% 68.63% 65.66% 64.89% 65.65% 65.41% 68.12% 70.04% 70.09% 70.59%
EBIT Margin
27.21% 23.77% 18.97% 16.60% 23.59% 22.25% 18.07% 26.72% 20.92% 18.32%
EBT margin
30.12% 25.87% 20.40% 17.01% 22.20% 21.15% 18.49% 26.94% 20.92% 18.22%
Net Profit Margin
23.13% 20.03% 15.56% 12.77% 17.42% 16.40% 15.30% 21.73% 17.03% 11.88%
Free Cash Flow Margin
29.83% 16.90% 15.24% 14.23% 19.57% 26.16% 8.89% 15.58% 16.31% 15.76%
EBITDA
79.20 61.93 46.23 36.26 47.50 37.18 26.60 32.53 25.16 19.93
EBIT
67.91 52.26 36.71 26.83 36.43 28.79 21.18 28.21 21.10 16.34
Income from Continuous Operations
57.73 44.04 30.11 20.64 26.91 21.22 17.93 22.94 17.18 10.59
Consolidated Net Income/Loss
57.73 44.04 30.11 20.64 26.91 21.22 17.93 22.94 17.18 10.59
EPS (Basic, from Continuous Ops)
2.55 1.96 1.36 0.94 1.27 1.05 0.91 1.18 0.91 0.57
EPS (Basic, Consolidated)
2.55 1.96 1.36 0.94 1.27 1.05 0.91 1.18 0.91 0.57
EPS (Diluted, from Cont. Ops)
2.52 1.93 1.34 0.93 1.25 1.04 0.88 1.13 0.86 0.55
Shares (Diluted, Average)
22.93 22.78 22.42 22.17 21.48 20.48 20.33 20.24 20.03 19.24
EPS (Diluted, Consolidated)
2.52 1.93 1.34 0.93 1.25 1.04 0.88 1.13 0.86 0.55
EBITDA Margin
31.73% 28.17% 23.89% 22.43% 30.76% 28.74% 22.69% 30.82% 24.94% 22.35%
Operating Cash Flow Margin
32.55% 20.07% 18.99% 15.70% 22.73% 26.90% 12.09% 18.48% 22.67% 18.95%

Fold the line items

In millions of $ except per-share values · columns are period end dates